Galera Therapeutics News

Galera Therapeutics | 10-Q: Quarterly report

May 13 07:34 ET

Galera Therapeutics | 8-K: Current report

May 13 07:09 ET

Galera Therapeutics | 8-K: Current report

May 3 16:31 ET

Galera Therapeutics | 8-A12B: Registration of a class of securities on a national securities exchange

May 3 16:15 ET

Galera Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-10% Owner Schneid Yair

May 1 17:07 ET

Galera Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Yair Schneid(19.90%)

May 1 17:03 ET

Galera Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-ALPHA PHARMA INVESTMENTS LLC - EIN:(5.056%)

Apr 16 16:41 ET

Galera Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Altamont Pharmaceutical Holdings, LLC(0%)

Apr 3 08:12 ET

Galera Therapeutics | 5: Annual statement of changes in beneficial ownership of securities-10% Owner Altamont Pharmaceutical Holdings, LLC

Apr 1 21:38 ET

Galera Therapeutics | 10-K: Annual report

Mar 28 07:34 ET

Galera Therapeutics | 8-K: Current report

Mar 28 07:09 ET

Galera Therapeutics | 8-K: Current report

Mar 27 07:34 ET

Galera Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Schneid Yair

Feb 26 16:12 ET

Galera Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Sofinnova Venture Partners IX, L.P. (“SVP IX”)(0.0%),Sofinnova Management IX, L.L.C. (“SM IX”)(0.0%), etc.

Feb 20 18:59 ET

Galera Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Sectoral Asset Management Inc(0%),Jérôme G. Pfund(0%), etc.

Feb 14 10:19 ET

Galera Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Yair Schneid(13.073%)

Jan 17 00:00 ET

Galera Therapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner Schneid Yair

Jan 16 00:00 ET

Galera Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-GSA Capital Partners LLP(7.156%)

Jan 2 00:00 ET

Galera Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Blackstone Inc.(4.2%),Blackstone Group Management L.L.C.(4.2%), etc.

Dec 4, 2023 16:32 ET

Galera Therapeutics: Q3 2023 Earnings Report

Nov 14, 2023 07:53 ET